Initial-Dose Tarlatamab-Associated Tumor Lysis Syndrome in Small Cell Lung Cancer
A single 1-milligram starter dose of the cancer immunotherapy tarlatamab was followed by a fatal case of tumour lysis syndrome ...
A single 1-milligram starter dose of the cancer immunotherapy tarlatamab was followed by a fatal case of tumour lysis syndrome ...
(Barcelona, Spain — September 8, 2025) — A pivotal multi-center, randomized phase III clinical trial has recently demonstrated that a ...
In a landmark development in the treatment of relapsed small cell lung cancer (SCLC), scientists have unveiled promising results from ...
In a groundbreaking development for the treatment of small cell lung cancer (SCLC), researchers have identified a novel therapeutic strategy ...
In a groundbreaking development in the treatment of small cell lung cancer (SCLC) patients with brain metastases, recent research has ...
Researchers at The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine